PSMA PET Imaging of Recurrent Prostate Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The purpose of this study is to see if a new diagnostic research agent named 68Ga-HBED-CC-PSMA can show prostate cancer on a PET/CT scan that cannot be seen on other standard imaging even when the PSA levels are very low.
Epistemonikos ID: 58101687950d7de03841a4f1bc2bc0f65b116170
First added on: May 20, 2024